Recommended dose of flutamide with LH-RH agonist therapy in patients with advanced prostate cancer.

MLA

Akaza, H., et al. “Recommended Dose of Flutamide with LH-RH Agonist Therapy in Patients with Advanced Prostate Cancer.” International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 3, no. 6, Nov. 1996, pp. 468–71. EBSCOhost, https://doi.org/10.1111/j.1442-2042.1996.tb00578.x.

APA

Akaza, H., Isaka, S., Usami, M., Kanetake, H., Kotake, T., Koiso, K., & Aso, Y. (1996). Recommended dose of flutamide with LH-RH agonist therapy in patients with advanced prostate cancer. International Journal of Urology : Official Journal of the Japanese Urological Association, 3(6), 468–471. https://doi.org/10.1111/j.1442-2042.1996.tb00578.x

Chicago

Akaza, H, S Isaka, M Usami, H Kanetake, T Kotake, K Koiso, and Y Aso. 1996. “Recommended Dose of Flutamide with LH-RH Agonist Therapy in Patients with Advanced Prostate Cancer.” International Journal of Urology : Official Journal of the Japanese Urological Association 3 (6): 468–71. doi:10.1111/j.1442-2042.1996.tb00578.x.